References
- Accardo A, Aloj L, Aurilio M, et al. (2014). Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs. Int J Nanomedicine 9:1537–57
- Accardo A, Salsano G, Morisco A, et al. (2012). Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. Int J Nanomedicine 7:2007–17
- Cabeza L, Ortiz R, Arias JL, et al. (2015). Enhanced anti-tumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles. Int J Nanomedicine 10:1291–306
- Carvalho C, Santos RX, Cardoso S, et al. (2009). Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16:3267–85
- Chanda N, Kattumuri V, Shukla R, et al. (2010). Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A 107:8760–5
- DeSantis C, Ma J, Bryan L, et al. (2014). Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62
- Doktorovova S, Souto EB, Silva AM. (2014). Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. Eur J Pharm Biopharm 87:1–18
- Han Y, Zhang Y, Li D, et al. (2014). Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomedicine 9:4107–16
- Jiang Z, Sun C, Yin Z, et al. (2012). Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems. Int J Nanomedicine 7:2019–31
- Jing F, Li J, Liu D, et al. (2013). Dual ligands modified double targeted nano-system for liver targeted gene delivery. Pharm Biol 51:643–9
- Khurana B, Goyal AK, Budhiraja A, et al. (2013). Lipoplexes versus nanoparticles: pDNA/siRNA delivery. Drug Deliv 20:57–64
- Kievit FM, Wang FY, Fang C, et al. (2011). Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release 152:76–83
- Kim KY, Kim SH, Yu SN, et al. (2015). Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin. Mol Med Rep 12:1898–904
- Kulhari H, Kulhari DP, Singh M, et al. (2014a). Colloidal stability and physicochemical characterization of bombesin conjugated biodegradable nanoparticles. Colloid Surfaces A 443:459–66
- Kulhari H, Pooja D, Shrivastava S, et al. (2014b). Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel. Colloids Surf B Biointerfaces 117:166–73
- Liu M, Chen D, Wang C, et al. (2015). Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. J Drug Target. [Epub ahead of print]. doi: 10.3109/1061186X.2015.1020427
- Liu Y, Wang L, Zhao Y, et al. (2014). Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm 476:169–77
- Müller RH, Shegokar R, Keck CM. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol 8:207–27
- Niknejad H, Mahmoudzadeh R. (2015). Comparison of different crosslinking methods for preparation of docetaxel-loaded albumin nanoparticles. Iran J Pharm Res 14:385–94
- Thukral DK, Dumoga S, Mishra AK. (2014). Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery. Curr Drug Deliv 11:771–91
- Toldo S, Goehe RW, Lotrionte M, et al. (2013). Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse. PLoS One 8:e58421
- Wang W, Zhou F, Ge L, et al. (2012). Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomedicine 7:2513–22
- Weber S, Zimmer A, Pardeike J. (2014). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm 86:7–22
- Wu G, Wang Z, Bian X, et al. (2014). Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy. Pharm Biol 52:978–82
- Zhao Y, Zhou Y, Wang D, et al. (2015). pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(d,l-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Acta Biomater 17:182–92